Mauricio Andrés Salazar Moreno

Dr. Mauricio Andrés Salazar Moreno

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
ALAlin Abreu Lomba
Alin Abreu Lomba
MTMaria Elena Tello-Cajiao
Maria Elena Tello-Cajiao
MGMónica Andrea Morales García
Mónica Andrea Morales García
AMAlexander Martínez
Alexander Martínez
MMMauricio Andrés Salazar Moreno
Mauricio Andrés Salazar Moreno
Juan S. Izquierdo-CondoyJuan S. Izquierdo-Condoy
Juan S. Izquierdo-Condoy
Background: Thyroid eye disease (TED), or Graves’ orbitopathy, is the most common extra-thyroidal manifestation of Graves’ disease, but it has only rarely been reported after SARS-CoV-2 vaccination. Autoimmune thyroid disease, including subacute thyroiditis and Graves’ disease, has been described following COVID-19 vaccination; we present a case series of TED occurring shortly after different COVID-19 vaccines to provide clinical data on this potential safety signal. Case presentation: We describe five women (mean age 47 years; range 27–69) who developed TED 3–20 days after COVID-19 vaccination with mRNA or adenoviral vector vaccines, three of whom had pre-existing thyroid disease. Presentations included ocular and retro-orbital pain, exophthalmos, headache, goiter, tremor, depressive symptoms, and, in one case, anterior neck pain and fever. TED severity (ETA/EUGOGO) ranged from mild to severe, with frequent findings of suppressed TSH, elevated thyroid autoantibodies, and inflammatory markers, as well as imaging evidence of exophthalmos, extraocular muscle enlargement, and diffuse or multinodular goiter. Management with intravenous corticosteroids, selenium, levothyroxine adjustment, and/or intramuscular corticosteroids led to improvement in thyroid function and inflammation by 3 months, although mild TED often persisted. Conclusions: This case series supports a temporal association between COVID-19 vaccination and new-onset or exacerbated TED in individuals with autoimmune thyroid disease. Although vaccination benefits outweigh potential risks, clinicians should remain alert to ocular and thyroid symptoms after immunization to ensure timely diagnosis and management.

5 July 2022 in Hepatología
Verified
Journal Article
Open access
MLMelissa Lara-Viáfara
Melissa Lara-Viáfara
MMMauricio Andrés Salazar Moreno
Mauricio Andrés Salazar Moreno
JSJuliana Suárez-Correa
Juliana Suárez-Correa
OROscar Reyna-Carrasco
Oscar Reyna-Carrasco
El hidrotórax hepático es una entidad poco frecuente en pacientes con cirrosis. A la fecha se han propuesto varias alternativas terapéuticas, tanto médicas como quirúrgicas, previas al trasplante hepático como manejo definitivo. A continuación, se presenta el caso de una paciente de 78 años con cirrosis secundaria a infección por virus de la hepatitis C, que acudió al servicio de urgencias por dificultad respiratoria, donde se documentó un derrame pleural derecho masivo de tipo trasudado, que respondió parcialmente a terapia diurética e inserción de dren pleural; posteriormente falleció por complicaciones hemorrágicas asociadas a la cirrosis. Se considera importante describir esta patología, dada su baja frecuencia en pacientes con cirrosis y los retos terapéuticos a los que nos enfrentamos con la poca evidencia disponible en la actualidad.